SODIUM VALPROATE AND CLONAZEPAM FOR TREATMENT-RESISTANT PANIC DISORDER

被引：0
|
作者：
ONTIVEROS, A [1 ]
FONTAINE, R [1 ]
机构：
[1] UNIV MONTREAL,LOUIS H LAFONTAINE HOSP,RES CTR,7331 HOCHELAGA,MONTREAL H1N 3M5,QUEBEC,CANADA
来源：
JOURNAL OF PSYCHIATRY & NEUROSCIENCE | 1992年 / 17卷 / 02期
关键词：
PANIC DISORDER; AGORAPHOBIA; CLONAZEPAM; SODIUM VALPROATE;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Sodium valproate (VA) and clonazepam (CLZ) were combined in the treatment of 4 patients with panic disorders (PD) who were resistant to several antipanic drug treatments. A significant improvement was found in the symptomatology of these patients, but relapses occurred when CLZ dosage was reduced. A potentiation of the GABAergic properties of VA and clonazepam is posulated. This combined treatment could be advantageous for some treatment-resistant PD patients but needs to be studied further.
引用
收藏
页码：78 / 80
页数：3
相关论文
共 50 条
  • [1] Clonazepam for the Treatment of Panic Disorder
    Nardi, Antonio E.
    Machado, Sergio
    Almada, Leonardo Ferreira
    Paes, Flavia
    Silva, Adriana Cardoso
    Marques, Ricardo Jose
    Amrein, Roman
    Freire, Rafael C.
    Martin-Santos, Rocio
    Cosci, Fiammeta
    Hallak, Jaime E.
    Crippa, Jose A.
    Arias-Carrion, Oscar
    CURRENT DRUG TARGETS, 2013, 14 (03) : 353 - 364
  • [2] Management of Treatment-Resistant Panic Disorder
    Perna G.
    Caldirola D.
    Current Treatment Options in Psychiatry, 2017, 4 (4) : 371 - 386
  • [3] Treatment-resistant panic disorder: a systematic review
    Freire, Rafael C.
    Zugliani, Morena M.
    Garcia, Rafael F.
    Nardi, Antonio E.
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (02) : 159 - 168
  • [4] Treatment-resistant panic disorder: clinical significance, concept and management
    Chen, Mu-Hong
    Tsai, Shih-Jen
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2016, 70 : 219 - 226
  • [5] PHARMACOGENETIC TESTING IN TREATMENT-RESISTANT PANIC DISORDER: A PILOT STUDY
    Freire, Rafael
    Fidry, Marcos
    Zugliani, Morena
    Cabo, Mariana
    Faria, Clara
    Nardi, Antonio
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 : i106 - i107
  • [6] Treatment-resistant anxiety disorders: social phobia, generalised anxiety disorder and panic disorder
    de Menezes, Gabriela Bezerra
    Fontenelle, Leonardo F.
    Mululo, Sara
    Versiani, Marclo
    REVISTA BRASILEIRA DE PSIQUIATRIA, 2007, 29 : S55 - S60
  • [7] Double-blind clonazepam vs placebo in panic disorder treatment
    Valença, AM
    Nardi, AE
    Nascimento, I
    Mezzasalma, MA
    Lopes, FL
    Zin, W
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2000, 58 (04) : 1025 - 1029
  • [8] VALPROATE TREATMENT OF PANIC DISORDER AND LACTATE-INDUCED PANIC ATTACKS
    KECK, PE
    TAYLOR, VE
    TUGRUL, KC
    MCELROY, SL
    BENNETT, JA
    BIOLOGICAL PSYCHIATRY, 1993, 33 (07) : 542 - 546
  • [9] Treating Treatment-Resistant Patients with Panic Disorder and Agoraphobia Using Psychotherapy: A Randomized Controlled Switching Trial
    Gloster, Andrew T.
    Sonntag, Rainer
    Hoyer, Juergen
    Meyer, Andrea H.
    Heinze, Simone
    Stroehle, Andreas
    Eifert, Georg
    Wittchen, Hans-Ulrich
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2015, 84 (02) : 100 - 109
  • [10] Combined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorder
    Pollack, MH
    Simon, NM
    Worthington, JJ
    Doyle, AL
    Peters, P
    Toshkov, F
    Otto, MW
    JOURNAL OF PSYCHOPHARMACOLOGY, 2003, 17 (03) : 276 - 282
12345